Tag ~genetics

Tag descriptions coming soon to Wherrelz News!


Seattle Genetics to acquire Cascadian Therapeutics for 614M to further bolster its cancer fight

Seattle Genetics finds mixed success in first earnings after Cascadian Therapeutics acquisition

Generation closes 1B growth fund targeting sustainable startups

Human sequencing pioneer George Church wants to give you the power to sell your DNA on the blockchain

Tech Moves: Former Amazon VP Brad Porter joins Scale AI as CTO Seattle startup Ally adds execs and more

Up to 818 million deal between JJ and Locus Biosciences points to a new path for CRISPR therapies

Scientists link mysterious snippets of DNA to cell growth and tumor suppression

Verily Alphabets other moneymaking nonGoogle business partners with Color on genetic analysis

Synthego raises 110 million to make gene editing technologies more accessible

Seattle Genetics COO taking the reins at stealthy biotech startup Silverback Therapeutics

Spiral Genetics relaunches inks Microsoft deal to predict heart disease with the human genome

23andMe raises 825 million in new funding

DNA testing startup Veritas Genetics confirms data breach

Optogenetics Market Modest Situation Among the Top Manufacturers With Sales Revenue and Market Share 2023

Tech Moves: Former Amazon VP Brad Porter joins Scale AI as CTO Seattle startup Allyio adds execs and more

Ancestrycom rejected a police warrant to access user DNA records on a technicality

23andMe might soon offer a more comprehensive 749 DNA service

Biodigital Architecture: FELIXprinters and iBAGUIC to Test Living Biomaterials for Sustainable Architecture

Sophia Genetics bags 77M Series E with 850 hospitals signed up to its datadriven medicine

Seattle Genetics drug rides FDA fasttrack to the front lines in fight against rare form of cancer

Tech Moves: Microsoft vet Qi Lu steps down at Baidu Seattle Genetics adds new chief medical officer and more

Reports about geneedited babies give birth to investigations in China and US

Molecular Cytogenetics Market Is Expected to Reach at a CAGR of 1094 by Regional Outlook Segmentation Application and Forecast to 2021

Sano Genetics a startup helping with Long Covid research raises 25M in seed funding

Seattle Genetics stock jumps 17 on breast cancer drug trial success

Washington State Univ spinout Dewey Scientific raises 125M to cultivate better cannabis buds

23andMe cofounders new startup Precisely brings genomics to India through Narayana partnership

Tech Moves: Former Amazon VP Brad Porter joins Scale AI as CTO UW names new Communication Leadership director and more

Canadian biotech company Chinook Therapeutics raises 65M for rare kidney disease therapies

A free web tool can predict your hair skin and eye color from DNA data

Life sciences startups in Eastern Washington find a welcoming ecosystem away from big cities

Scientists program semisynthetic bacteria to create an alien protein that glows green

Emerging from stealth Octant is bringing the tools of synthetic biology to large scale drug discovery

Historic steam plant in Seattle gets a fresh new look courtesy of Fred Hutch

Driving down the cost of preserving genetic material Acorn Biolabs raises 33 million

Seattle Genetics beats earnings expectations as lead drug Adcetris finds market success

COVID19 and Trump visa ban leave South Africa biotech startup in limbo as it plots move to Seattle

Epigenetics Drugs and Diagnostic Technologies Market 20212027 Latest COVID19 Impact Analysis Novartis AG Illumina Inc Eisai Co Ltd

The genomicsfocused Illumina Accelerator backs five new companies

Youve heard of CRISPR now meet its newer savvier cousin CRISPR Prime

Hospital in China denies links to worlds first geneedited babies

George Churchs genetics on the blockchain startup just raised 43 million from Khosla

Tech Moves: PicMonkey cofounder Lisa Conquergood joins Ripl Starbucks hires tech vet as general counsel and more

Prenetics partners with Watsons one of Asias largest personal care retailers to sell its new consumer DNA tests

Cyrus Biotechnology and CRISPR pioneers team up to boost geneediting therapies

With new Partner Colin Hanna and Shikha Ahluwalia as Associate Balderton puts down roots in Berlin

Mercks multibillion dollar bet on Seattle Genetics sparks hope for breast cancer treatments

These tech stocks were the biggest winners and losers in the Seattle area for 2019

Phase Genomics wins 15M grant to peer inside microorganisms DNA

Companies tracking mutations in cancer cells can provide a key to unlocking better therapies